ADIM
IAS

Alpha DNA Investment Management’s Integral Ad Science IAS Stock Holding History

Alpha DNA Investment Management’s Portfolio IAS Stock Details IAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-42,274
Closed -$411K – 220
2024
Q2 		$411K Buy
+42,274
New +$405K 0.16% 157
2024
Q1 		– Sell
-39,555
Closed -$569K – 221
2023
Q4 		$569K Buy
+39,555
New +$529K 0.22% 88

Other funds holding IAS

VEPM
Vista Equity Partners Management San Francisco, California $23.2M AUM 39.97% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $637M AUM 2.87% 1-Year Est. Return
PCP
P2 Capital Partners New York $246M AUM 17.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Alpha DNA Investment Management's IAS Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of Integral Ad Science (IAS) in Q3 2024, closing a stake of 42,274 shares — an estimated $411K sold.

Alpha DNA Investment Management first reported a position in IAS in Q4 2023 and held it in 2 quarters. The position peaked at $569K in Q4 2023. 172 funds tracked by Wall St. Rank hold IAS as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining Integral Ad Science position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 42,274 Integral Ad Science shares in Q3 2024, an estimated $411K.
  • Alpha DNA Investment Management first reported a position in Integral Ad Science in Q4 2023 and held it in 2 quarters.
  • Alpha DNA Investment Management's Integral Ad Science position peaked at $569K in Q4 2023.
  • 172 funds tracked by Wall St. Rank held Integral Ad Science as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.